Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (53)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Romach, E. H.
Right arrow Articles by Waalkes, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romach, E. H.
Right arrow Articles by Waalkes, M. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 54, 500-508 (2000)
Copyright © 2000 by the Society of Toxicology

Studies on the Mechanisms of Arsenic-Induced Self Tolerance Developed in Liver Epithelial Cells through Continuous Low-Level Arsenite Exposure

Elizabeth H. Romach*, Christopher Q. Zhao*, Luz María Del Razo{dagger}, Mariano E. Cebrián{dagger} and Michael P. Waalkes*,1

* Inorganic Carcinogenesis Section, Laboratory of Comparative Carcinogenesis, National Cancer Institute at the National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina; and {dagger} Pharmacology and Toxicology, CINVESTAV-IPN, Mexico City, Mexico

Arsenic (As) is a human carcinogen. Our prior work showed that chronic (>18 weeks) low level (500 nM) arsenite (As3+) exposure induced malignant transformation in a rat liver epithelial cell line (TRL 1215). In these cells, metallothionein (MT) is hyper-expressible, a trait often linked to metal tolerance. Thus, this study examined whether the adverse effects of arsenicals and other metals were altered in these chronic arsenite-exposed (CAsE) cells. CAsE cells, which had been continuously exposed to 500 nM arsenite for 18 to 20 weeks, and control cells, were exposed to As3+, arsenate (As5+), dimethylarsinic acid (DMA), monomethylarsonic acid (MMA), antimony (Sb3+), cadmium (Cd2+), cisplatin (cis-Pt), and nickel (Ni2+) for 24 h and cell viability was determined by metabolic integrity. The lethal concentration for 50% of exposed cells (LC50) for As3+ was 140 µM in CAsE cells as compared to 26 µM in control cells, a 5.4-fold increase in tolerance. CAsE cells were also very tolerant to the acute toxic effects of As5+ (LC50 > 4000 µM) compared to control (LC50 = 180 µM). The LC50 for DMA was 4.4-fold higher in CAsE cells than in control cells, but the LC50 for MMA was unchanged. There was a modest cross-tolerance to Sb3+, Cd2+, and cis-Pt in CAsE cells (LC50 1.5–2.0-fold higher) as compared to control. CAsE cells were very tolerant to Ni2+ (LC50 > 8-fold higher). Culturing CAsE cells in As3+-free medium for 5 weeks did not alter As3+ tolerance, implicating an irreversible phenotypic change. Cellular accumulation of As was 87% less in CAsE cells than control and the accumulated As was more readily eliminated. Although accumulating much less As, a greater portion was converted to DMA in CAsE cells. Altered glutathione (GSH) levels were not linked with As tolerance. A maximal induction of MT by Zn produced only a 2.5-fold increase in tolerance to As3+ in control cells. Cell lines derived from MT normal mice (MT+/+) were only slightly more resistant (1.6-fold) to As3+ than cells from MT null mice (MT-/-). These results show that CAsE cells acquire tolerance to As3+, As5+, and DMA. It appears that this self-tolerance is based primarily on reduced cellular disposition of the metalloid and is not accounted for by changes in GSH or MT.

Key Words: arsenic; zinc; tolerance; metallothionein; cytotoxicity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
C. Kojima, D. C. Ramirez, E. J. Tokar, S. Himeno, Z. Drobna, M. Styblo, R. P. Mason, and M. P. Waalkes
Requirement of Arsenic Biomethylation for Oxidative DNA Damage
J Natl Cancer Inst, November 23, 2009; (2009) djp414v1.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-F. Coppin, W. Qu, and M. P. Waalkes
Interplay between Cellular Methyl Metabolism and Adaptive Efflux during Oncogenic Transformation from Chronic Arsenic Exposure in Human Cells
J. Biol. Chem., July 11, 2008; 283(28): 19342 - 19350.
[Abstract] [Full Text] [PDF]


Home page
International Journal of ToxicologyHome page
S. Ghosh, S. De, and S. K. Dutta
Altered Protein Expressions in Chronic PCB-153-Induced Human Liver (HepG2) Cells
International Journal of Toxicology, May 1, 2007; 26(3): 203 - 212.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. K. Holzer, G. H. Manorek, and S. B. Howell
Contribution of the Major Copper Influx Transporter CTR1 to the Cellular Accumulation of Cisplatin, Carboplatin, and Oxaliplatin
Mol. Pharmacol., October 1, 2006; 70(4): 1390 - 1394.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
A. K. Holzer, N. M. Varki, Q. T. Le, M. A. Gibson, P. Naredi, and S. B. Howell
Expression of the Human Copper Influx Transporter 1 in Normal and Malignant Human Tissues
J. Histochem. Cytochem., September 1, 2006; 54(9): 1041 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. Kojima, W. Qu, M. P. Waalkes, S. Himeno, and T. Sakurai
Chronic Exposure to Methylated Arsenicals Stimulates Arsenic Excretion Pathways and Induces Arsenic Tolerance in Rat Liver Cells
Toxicol. Sci., May 1, 2006; 91(1): 70 - 81.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. K. Holzer, K. Katano, L. W. J. Klomp, and S. B. Howell
Cisplatin Rapidly Down-regulates Its Own Influx Transporter hCTR1 in Cultured Human Ovarian Carcinoma Cells
Clin. Cancer Res., October 1, 2004; 10(19): 6744 - 6749.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
X. Lin, T. Okuda, A. Holzer, and S. B. Howell
The Copper Transporter CTR1 Regulates Cisplatin Uptake in Saccharomyces cerevisiae
Mol. Pharmacol., November 1, 2002; 62(5): 1154 - 1159.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L.-H. Yih, K. Peck, and T.-C. Lee
Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment
Carcinogenesis, May 1, 2002; 23(5): 867 - 876.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Qu, B. A. Diwan, J. Liu, R. A. Goyer, T. Dawson, J. L. Horton, M. G. Cherian, and M. P. Waalkes
The Metallothionein-Null Phenotype Is Associated with Heightened Sensitivity to Lead Toxicity and an Inability to Form Inclusion Bodies
Am. J. Pathol., March 1, 2002; 160(3): 1047 - 1056.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W. Qu, C. D. Bortner, T. Sakurai, M. J. Hobson, and M. P. Waalkes
Acquisition of apoptotic resistance in arsenic-induced malignant transformation: role of the JNK signal transduction pathway
Carcinogenesis, January 1, 2002; 23(1): 151 - 159.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
W. Qu, K. S. Kasprzak, M. Kadiiska, J. Liu, H. Chen, A. Maciag, R. P. Mason, and M. P. Waalkes
Mechanisms of Arsenic-Induced Cross-Tolerance to Nickel Cytotoxicity, Genotoxicity, and Apoptosis in Rat Liver Epithelial Cells
Toxicol. Sci., October 1, 2001; 63(2): 189 - 195.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Liu, H. Chen, D. S. Miller, J. E. Saavedra, L. K. Keefer, D. R. Johnson, C. D. Klaassen, and M. P. Waalkes
Overexpression of Glutathione S-Transferase II and Multidrug Resistance Transport Proteins Is Associated with Acquired Tolerance to Inorganic Arsenic
Mol. Pharmacol., August 1, 2001; 60(2): 302 - 309.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Liu, Y. Liu, R. A. Goyer, W. Achanzar, and M. P. Waalkes
Metallothionein-I/II Null Mice Are More Sensitive than Wild-Type Mice to the Hepatotoxic and Nephrotoxic Effects of Chronic Oral or Injected Inorganic Arsenicals
Toxicol. Sci., June 1, 2000; 55(2): 460 - 467.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.